1-Propyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide, 97%, 10g

tert-Butyl 2-oxoindoline-1-carboxylate, 95.0%, 5g

2-Amino-1- o -tolyl-ethanone; hydrochloride, 1g

Methyl 2-Pyrazinecarboxylate>98.0%(GC)25g

(1S)-2′-[[Bis(1-methylethyl)amino]carbonyl][1,1′-binaphthalene]-2-carboxylic acid, 1g

6-METHOXYTETRALIN-5-CARBOXYLIC ACID, 95%, 1g

Methyl benzofuran-2-carboxylate, 95.0%, 1g

5-Amino-2-methyl-2H-tetrazole, 95.0%, 5g

4-Amino-1-benzylpyrrolidin-2-one hydrochloride, 95.0%, 10g

NHS-PEG2-SS-PEG2-NHS, 250mg

(Tetrahydrofuran-2-yl)methyl acrylate (stabilized with MEHQ), 98.00%, 100g

Savolitinib, 99.90%, 50mg

2-Pentene (cis- and trans- mixture), 95.0%, 100mg